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Abstract 
Article History 
 
Objectives: To estimate the prevalence of hypoalbuminemia in acute febrile medical illness 
and whether the degree of hypoalbuminemia correlates with other markers of disease 
severity.  
Materials and methods: Acute febrile illness was defined as a febrile illness (t>101˚f) of 
less than 7 days.  The study inclusion criteria was acute febrile illnesses with at least two 
organ dysfunctions and excluded those with pre-existing confounding diseases.   At 
admission, serum albumin and other markers of organ dysfunction were recorded.  In 
recovered patients, serum albumin was repeated at their first follow up.  Patients were 
grouped according to admission albumin levels into group 1 (<2.4gms/dl.), group II  
(<2.9gm/dl ≥2.5 gm/dl) and  group III ( >3gm/dl).   
Results: Of 121 included in the study, 118 (97.5%) had hypoalbuminaemia (<3.5gm/dl) at 
admission with a mean admission albumin level of 2.7gm/dl.  81 patients came for follow up 
and repeat albumin levels could be done in 63. All showed improvement in albumin levels 
with a mean albumin 3.5gm/dl at follow up.  Of the total of 121 patients, 35 patients (29%) 
were categorized as group I, 52 patients (42%) as group II, and 34 patients (29%) as group 
III. Group I patients compared to the other two groups showed significant differences in  
hypotension (54% vs 32% vs 26%, p- 0.001); need for ventilatory support  (60% vs 29% vs 
14%, p-.0001) and renal failure (51% vs 25% vs 17%, p-.04). 
Conclusions: Hypoalbuminaemia occurs frequently in acute febrile illness and appears to 
be a simple marker of disease severity and morbidity.  
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Introduction 
The serum albumin level is one of the parameters 
reflecting the status of general health1,2. Hypoalbuminemia 
frequently occurs in acute medical illness3, but its clinical 
significance is not well known.  A decrease in serum albumin 
concentration is an almost inevitable finding in severe disease 
states, and is primarily mediated in the acute phase by 
alterations of vascular permeability and redistribution of fluid.  
This change is not disease specific, but marked 
hypoalbuminemia that persists is generally associated with a 
poor prognosis3,4,5,6.  This study was designed to see if hypo-
albuminemia serves as a marker of disease severity in those 
with acute febrile illnesses.   The study compared the severity 
of hypoalbuminemia with the more conventional markers of 
serious disease.  
Materials and Methods   
All patients admitted in the high dependency areas of 
Kasturba Hospital, Manipal from January 2007 to May 2008 
with an acute febrile medical illness (defined below) in whom 
albumin levels could be measured within 24 hrs of admission 
were included in the study.  The dye binding automated 
technique with bromo-cresol green was used for serum 
albumin measurement.  
Inclusion criteria: Any patient in the age group of 18-60 years 
with a febrile illness of less than seven days duration and 
clinical or laboratory evidence of at least two or more major 
organ dysfunctions.   
Exclusion criteria: Patients with age <18 years and >60 years 
or other associated comorbid conditions like diabetes mellitus, 
alcoholism, chronic liver disease, chronic kidney disease, 
malabsorption, burns, pregnancy, HIV infection, malignancies 
or those given exogenous albumin/plasma.   
In all patients satisfying the inclusion and exclusion 
criteria the following parameters were documented: clinical 
signs and symptoms, admission laboratory values of 
hemoglobin, hematocrit, platelet and leukocyte counts, 
prothrombin time, blood urea, serum creatinine, serum 
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albumin, serum total bilirubin, aspartate aminotransferase 
(AST), alanine aminotransferase (ALT) and alkaline 
phosphatase (ALP). Patients were monitored for the 
development of hypotension, renal failure, requirement for 
ventilatory support and the final outcome or mortality.  The 
patients were divided into three groups based on the 
admission level of serum albumin:  group I (serum albumin 
<2.4 g/dl), group II (serum albumin ≥2.5 to 2.9 g/dl), and group 
III (serum albumin >3 g/dl). Laboratory and clinical parameters 
were then compared among the three groups, using statistical 
methods.  
In patients with complete recovery serum albumin was 
repeated at the first out-patient follow-up. The criteria used to 
define organ system involvement were as follows - 
Respiratory System: PaO2 <70mm of Hg or oxygen 
saturation less than 90% on pulse oximetry in room air or 
PaO2/FiO2 <250 or if the lung is the only dysfunctional organ 
<200. Cardiovascular System: Systolic BP <90mmHg or 
10mmHg lower than patient’s normal BP for at least 1 hour 
despite adequate fluid resuscitation or need for vasopressors 
to maintain systolic BP >90 mm of Hg or mean arterial 
pressure>70 mm of Hg.  Renal System: Urine output 
<0.5ml/kg or <30ml/hour despite adequate fluid resuscitations 
or serum creatinine >2mg/dl.  Hematological System: Platelet 
count <1,00,000/cumm or WBC <4,000/cumm or 
>12,000/cumm with >10% bands or prolonged prothrombin 
time >6 secs compared to control. Hepatobiliary System: 
Serum total bilirubin > 2 mg/dl or raised AST and ALT more 
than twice the upper limit of normal. The parameters 
representing severity of acute febrile illness included in our 
study were hypotension, renal failure, need for ventilatory 
support, increased total bilirubin, increased AST/ALT/ALP, 
prolonged PT, thrombocytopenia, leucocytosis and overall 
mortality.  
Statistical Methods: SPSS 13.0 for windows was used for 
statistical analysis. Data were recorded on a pre-designed 
proforma.  Before entering the data on the excel spreadsheet, 
the proforma was reviewed for incomplete information.  Results 
was expressed as mean and SD. One way analysis of variance 
(ANOVA) was used for analyzing differences among groups. 
Pearson’s  correlation  coefficient, linear  by  linear association  
was  used  to determine the  relationship  between  the  lowest  
level  of serum  albumin and laboratory values. Chi squared 
test was used for comparison of qualitative data. Statistical 
significance was defined as p<0.05.  
Results 
All 121 patients (M/F - 68/53) who met the criteria for the 
study were grouped into three groups based on their admission 
serum albumin: Group 1 (<2.4gms/dl.), Group 2 (<2.9g/dl and 
≥2.5 g/dl), and Group 3 (>3g/dl).  35 patients (29%) were in 
Group I, 52 patients (42%) in Group II, and 34 patients (29%) 
in Group III.  Mean age in group 1 was 39 (SD-11.1), in group 
2 it was 37 (SD-12.1) and group 3 it was 34.5 years(SD-8.7).  
63% of the patients were <40 years in age. 118 (97.5%) 
patients had hypo-albuminemia (<3.5gm/dl) at presentation 
with the mean serum albumin level being 2.7gm/dl.  The 
following were the diagnosed causes of acute febrile illnesses -
  systemic viral illness in 38(31.4%), dengue in 27(22.3%), 
leptospirosis in 22(18.2%), sepsis syndrome in 21(17.3%), 
falciparum malaria in 9(7.4%), vivax malaria, typhoid fever, 
brucellosis and scrub typhus infection  in 1 each (3.3%).  The 
diagnosis of systemic viral illness was made after reasonably 
excluding common bacterial, viral and parasitic illnesses by 
appropriate tests. 
102(84.3%) patients recovered from the acute febrile 
illness and were discharged.  The mean duration of 
hospitalization was 10.9 days (SD 3.9).  81(79.4%) of the 
patients had come for outpatient follow up and had completely 
recovered, but a repeat serum albumin could be done only in 
63 of them (i.e. 61.76% of the original study group or 77.8% of 
the ones who came for follow-up).  This showed improvement 
with a mean albumin of 3.5gm/dl (SD 0.46). The median follow 
up period was 21 days.  Mean albumin levels in the 3 groups at 
follow-up compared to the initial values showed a statistically 
significant rise on univariate analysis of variance ANOVA 
(p<0.01) (Figure 2).   
On subgroup analysis comparing the various groups and 
the other parameters representing disease severity namely 
hypotension, renal failure, need for ventilatory support and 
mortality (Figure 1); Group 1 compared to  Group 2 and Group 
3 had a higher incidence of  hypotension (54% vs 32% vs 26% 
- p 0.001), need for  ventilatory support (60% vs 29% vs 14% - 
p 0.0001 ) and  renal failure (51% vs 25% vs 17% - p 0.04).   
Mortality in the 3 groups were (20% vs 15% vs 11.8% - p 
0.349) and did not show a statistically significant difference.  
The overall mortality in the entire group was 15%.  There was 
no correlation with other parameters of morbidity like length of 
hospitalization, raised liver enzymes and low platelet counts 
(Table.2)  
 
 
 
 
 
 
 
 
 
 
 
 
Figure.1: Morbidity parameters compared between various groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Comparison of mean increase in albumin 
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Table:1)Various Parameters In Three Groups 
Variables Group-1 (Alb. < 2.4 g/dl) 
Group-2 
(Alb. 2.5 – 2.9 g/dl) 
Group-3 
(Alb. > 3 g/dl) 
No of patients 35(29%) 52(42%) 34(29%) 
Male:female 18:17 29:23 13:21 
Mean age 39(SD 11.1) 37(SD 12.1) 34.5(SD 8.7) 
Systemic viral 
illness 13 14 10 
Sepsis 3 11 8 
Dengue 7 14 6 
Leptopirosis 9 7 6 
Falciparum 
malaria 2 4 3 
Vivax malaria 0 0 1 
Typhoid 0 1 0 
Brucellosis 0 1 0 
Typhus infection 1 0 0 
Mean albumin at 
admission 2.188 g/dl(SD 0.16) 2.69 g/dl(SD 0.14) 3.25 g/dl(SD 0.28) 
Mean albumin at 
follow up 3.34 g/dl(SD 0.65) 3.45 g/dl(SD 0.50) 3.84 g/dl(SD 0.45) 
Median duration at 
follow up (days) 30.06 24.03 19.07 
Mean duration of 
hospitilasation in 
days 
12.7(SD 4.4) 10.55(SD 4.3) 9.5(SD 3.2) 
 
Table 2: Median values of morbidity parameters in various groups 
 
PARAMETERS GROUP 1 GROUP 2 GROUP 3 
Total Bilirubin (mg/dl) 3.7 3.9 1.4 
AST (IU/L) 232 179 185 
ALT (IU/L) 92 89 99 
ALP (IU/L) 241 221 152 
Platelet counts 
(x103/µL) 53 50.5 49.5 
WBC count 
(x103/µL) 11.6 9.95 8.25 
 
Discussion  
This study was done as we had noted that 
hypoalbuminemia was not an uncommon occurrence in 
individuals with short febrile illnesses without pre-existing 
diseases.  
In this study only febrile illness of less than 7 days were 
included to decrease the chance of confounding variables like 
decreased food intake affecting albumin levels.  Seven days 
was chosen as the half life albumin is normally 19 days 5,6,7.  
Similarly, albumin levels are known to decrease by 9.7% for 
each decade after 60 years of age8,9.  The age group in this 
study was 18-60 years and was therefore chosen to avoid 
chances of age related changes on albumin levels.  Most of the 
patients were young (<40 years of age - 68%) where one 
would expect good albumin levels.   
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The inclusion criteria for this study besides a short febrile 
illness, was the presence of at least two organ dysfunctions.   
Hypoalbuminemia was seen in 97.5% (118/121) of the study 
population; only 3 patients had a serum albumin level more 
than 3.5gm/dl.  This is a very high prevalence considering that 
the exclusion criteria excluded most common co-morbid 
conditions.  This therefore reflects the severe nature of the 
acute illness in these individuals.  
To verify that the hypoalbuminemia had occurred as part of the 
acute febrile medical illness, the patients were followed up 
after discharge from hospital and the serum albumin repeated 
at the first follow up a few weeks later.  81 patients came for 
follow up and among them 63(61.8% of the original group or 
77.4% of the ones who came for follow-up) had repeat albumin 
levels. The mean albumin at admission was 2.7g/dl and at 
follow up had increased to 3.5g/dl which was statistically 
significant (p<0.01).  This confirms that the drop in albumin 
levels was part of the acute illness and is well described in 
inflammatory disorders10,11,12,13,14.  
The mechanisms underlying hemodyamic compromise in 
acute febrile illness are the consequence of widespread 
vascular changes of which increased vascular permeability and 
impaired vascular tone are the most important and is mediated 
by inflammatory mediators and endotoxins15. Marked vascular 
permeability leads to third space fluid loss, hypotension and 
severe systemic organ dysfunction.  ARDS, ascites, pleural 
and pericardial effusions reflect vascular leakage secondary to 
vascular endothelial injury. Severe acute systemic illness is 
known to alter the distribution of albumin between the 
intravascular and extravascular compartments.  Albumin is 
known to decrease very early in these illnesses due to 
changes in the vascular permeability and hydrostatic and 
oncotic pressures across the capillaries.  There is also an 
acute shut down of albumin synthesis in the liver due to 
increased synthesis of acute phase proteins in acute febrile 
illness and an altered catabolism of albumin16,17.  
The study looked at the relationship between the levels of 
serum albumin and clinical parameters representing severity of 
disease. To evaluate this, patients were grouped into three 
groups   based on the admission serum albumin: Group 1 
(<2.4gms/dL), Group 2 (serum albumin <2.9 g/dL and ≥2.5 
g/dL), and Group 3 (serum albumin >3g/dL).  These three 
groups were compared to standard severity and morbidity 
parameters like hypotension, renal failure, need for ventilatory 
support, deaths, liver dysfunction and thrombocytopenia. 
Group 1 had a higher incidence of hypotension, need for 
ventilatory support, renal failure and mortality than groups 2 
and 3.  Hypoalbuminemia in severe acute febrile illness 
statistically correlated with conventional markers of morbidity 
like hypotension, need for ventilatory support and renal failure.  
It did not show as good a correlation for mortality rates. 
A similar conclusion was reached in a Cochrane meta-
analysis done in ICU patients that had collected data from 
291,433 patients in medical and surgical ICUs and showed that 
hypo-albuminemia at admission was a good outcome 
predictor18.  However, this Cochrane meta-analysis was done 
on a heterogenous group of patients which ranged from 
patients with myocardial infarctions to postoperative surgical 
patients and the only criteria was the need for ICU admission. 
Patients with coexisting diseases like renal failure, liver failure 
and others were also not excluded. We have been unable to 
find any reference to a study like ours which was restricted to 
short febrile illness in patients who had no apparent pre-
existing disease. The closest that could be found was a study 
from South Korea in patients with Hanta virus renal syndrome 
which showed statistical correlation of hypoalbuminaemia with 
morbidity, length of hospitalization, liver enzymes and 
mortality19.  The problem with Hanta virus renal disease is that 
it is a condition which primarily involves the kidneys and 
therefore it would not be surprising that the serum albumin 
levels were more likely to be a reflection of proteinuria rather 
than the severity of systemic illness.  
In this study hypotension, need for ventilator support and 
renal failure correlated statistically with the severity of 
hypoalbuminaemia. There was no good correlation with 
mortality but in crude terms the incidence was higher in Group 
1 which had the lowest serum albumin levels. The overall 
mortality in entire group was 15%.  It is possible that if the 
series were larger a statistical correlation with mortality might 
also have been detected. 
The study did not show correlation with other parameters 
of morbidity like length of hospitalization, raised liver enzymes 
and low platelet counts. This could partly be due to the fact 
that, the study population was a miscellaneous bag of illness, 
ranging from viral illness like dengue to bacterial sepsis and 
severe malaria.  Each of these diseases is likely to have 
different presentations which predominate and could have 
affected the overall interpretations of these individual 
parameters.  Ideally it would have been better to look and see 
if hypoalbuminemia correlated with some of these indices in 
each individual disease.  This was not done as the numbers for 
each individual disease was small once the strict exclusion 
criteria were applied.  It therefore appears that a simple test 
like an albumin level at admission is a good indicator of 
severity of disease in individuals with short febrile illnesses and 
could be a useful prognostic marker.  It is a reflection of the 
extent of the disease process and the pathological effects seen 
in severe disease.  It is clearly the effect of disease and not the 
cause as is shown by prompt improvement on recovery. 
Recovery to normal albumin levels is also probably a good 
indicator that the patient has surmounted the effects of the 
acute ‘insult’ he had and is on the road to recovery. 
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